Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981124574> ?p ?o ?g. }
- W1981124574 endingPage "421" @default.
- W1981124574 startingPage "421" @default.
- W1981124574 abstract "To investigate integrin beta3 mRNA and vascular endothelial growth factor (VEGF) protein expression in gastric carcinoma, and its correlation with microvascular density, growth-pattern, invasion, metastasis and prognosis.In situ hybridization(ISH) of integrin beta3 mRNA and immunohistochemistry of VEGF and CD34 protein were performed on samples from 118 patients with gastric cancer.The positive rate of integrin beta3 mRNA in non-tumor gastric mucosa (20%) was significantly lower than that of the gastric cancer tissue (52.5%, c2 = 10.20, P < 0.01). In patients of infiltrating type, stage T(3)-T(4), vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of integrin beta3 mRNA were significantly higher than those in patients of expanding type (P < 0.01), stage T(1)-T(2) (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T(3)-T(4), vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of VEGF protein were significantly higher than those in patients of expanding type (P < 0.01), stage T(1)-T(2) (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T(3)-T(4), vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the mean MVD were significantly higher than those in patients of expanding type (P < 0.01), stage T(1)-T(2) (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. It was found that the positive expression rate of integrin beta3 mRNA was positively related to that of VEGF protein (P < 0.01) and MVD (P < 0.05), meanwhile the positive expression rate of VEGF protein was positively related to MVD (P < 0.05). The mean survival period in patients with positive expression of integrin beta3 mRNA and VEGF, and MVD > or = 54.9/mm(2) was significantly shorter than that in patients with negative expression of integrin beta3 mRNA (P < 0.05) and VEGF (P < 0.01), and MVD < 54.9/mm(2) (P < 0.01). Five-year survival rate in patients with positive expression of integrin beta3 mRNA and VEGF, and MVD > or = 54.9/mm(2) was significantly lower than those with negative expression of integrin beta3 mRNA (P < 0.05), VEGF (P < 0.05), and MVD < 54.9/mm(2) (P < 0.01).Integrin beta3 and VEGF expression can synergistically enhance tumor angiogenesis, and may play a crucial role in invasion and metastasis of gastric carcinoma. Therefore, they may be prognostic biomarkers and novel molecular therapeutic targets." @default.
- W1981124574 created "2016-06-24" @default.
- W1981124574 creator A5017347549 @default.
- W1981124574 creator A5024445158 @default.
- W1981124574 creator A5024985310 @default.
- W1981124574 creator A5041378395 @default.
- W1981124574 creator A5056747247 @default.
- W1981124574 creator A5069575896 @default.
- W1981124574 date "2008-01-01" @default.
- W1981124574 modified "2023-10-10" @default.
- W1981124574 title "Correlation of integrin β3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma" @default.
- W1981124574 cites W1576773659 @default.
- W1981124574 cites W1580211231 @default.
- W1981124574 cites W1595810968 @default.
- W1981124574 cites W1679229092 @default.
- W1981124574 cites W1783580437 @default.
- W1981124574 cites W1964433907 @default.
- W1981124574 cites W1979306439 @default.
- W1981124574 cites W1995470316 @default.
- W1981124574 cites W2008609171 @default.
- W1981124574 cites W2018159680 @default.
- W1981124574 cites W2033987226 @default.
- W1981124574 cites W2082313852 @default.
- W1981124574 cites W2085904846 @default.
- W1981124574 cites W2092323746 @default.
- W1981124574 cites W2099487193 @default.
- W1981124574 cites W2104755948 @default.
- W1981124574 cites W2108059110 @default.
- W1981124574 cites W2108713158 @default.
- W1981124574 cites W2125672675 @default.
- W1981124574 cites W2129240576 @default.
- W1981124574 cites W2130284298 @default.
- W1981124574 cites W2130580559 @default.
- W1981124574 cites W2146067949 @default.
- W1981124574 cites W2320817256 @default.
- W1981124574 cites W294193587 @default.
- W1981124574 cites W4255358151 @default.
- W1981124574 doi "https://doi.org/10.3748/wjg.14.421" @default.
- W1981124574 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2679131" @default.
- W1981124574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18200665" @default.
- W1981124574 hasPublicationYear "2008" @default.
- W1981124574 type Work @default.
- W1981124574 sameAs 1981124574 @default.
- W1981124574 citedByCount "26" @default.
- W1981124574 countsByYear W19811245742012 @default.
- W1981124574 countsByYear W19811245742013 @default.
- W1981124574 countsByYear W19811245742015 @default.
- W1981124574 countsByYear W19811245742019 @default.
- W1981124574 countsByYear W19811245742020 @default.
- W1981124574 countsByYear W19811245742021 @default.
- W1981124574 countsByYear W19811245742022 @default.
- W1981124574 crossrefType "journal-article" @default.
- W1981124574 hasAuthorship W1981124574A5017347549 @default.
- W1981124574 hasAuthorship W1981124574A5024445158 @default.
- W1981124574 hasAuthorship W1981124574A5024985310 @default.
- W1981124574 hasAuthorship W1981124574A5041378395 @default.
- W1981124574 hasAuthorship W1981124574A5056747247 @default.
- W1981124574 hasAuthorship W1981124574A5069575896 @default.
- W1981124574 hasBestOaLocation W19811245741 @default.
- W1981124574 hasConcept C103041312 @default.
- W1981124574 hasConcept C121608353 @default.
- W1981124574 hasConcept C126322002 @default.
- W1981124574 hasConcept C142724271 @default.
- W1981124574 hasConcept C146285616 @default.
- W1981124574 hasConcept C167734588 @default.
- W1981124574 hasConcept C181152851 @default.
- W1981124574 hasConcept C204232928 @default.
- W1981124574 hasConcept C2777025900 @default.
- W1981124574 hasConcept C2778740770 @default.
- W1981124574 hasConcept C2779013556 @default.
- W1981124574 hasConcept C2780965494 @default.
- W1981124574 hasConcept C71924100 @default.
- W1981124574 hasConceptScore W1981124574C103041312 @default.
- W1981124574 hasConceptScore W1981124574C121608353 @default.
- W1981124574 hasConceptScore W1981124574C126322002 @default.
- W1981124574 hasConceptScore W1981124574C142724271 @default.
- W1981124574 hasConceptScore W1981124574C146285616 @default.
- W1981124574 hasConceptScore W1981124574C167734588 @default.
- W1981124574 hasConceptScore W1981124574C181152851 @default.
- W1981124574 hasConceptScore W1981124574C204232928 @default.
- W1981124574 hasConceptScore W1981124574C2777025900 @default.
- W1981124574 hasConceptScore W1981124574C2778740770 @default.
- W1981124574 hasConceptScore W1981124574C2779013556 @default.
- W1981124574 hasConceptScore W1981124574C2780965494 @default.
- W1981124574 hasConceptScore W1981124574C71924100 @default.
- W1981124574 hasIssue "3" @default.
- W1981124574 hasLocation W19811245741 @default.
- W1981124574 hasLocation W19811245742 @default.
- W1981124574 hasLocation W19811245743 @default.
- W1981124574 hasLocation W19811245744 @default.
- W1981124574 hasOpenAccess W1981124574 @default.
- W1981124574 hasPrimaryLocation W19811245741 @default.
- W1981124574 hasRelatedWork W1819192711 @default.
- W1981124574 hasRelatedWork W1968237864 @default.
- W1981124574 hasRelatedWork W2017828562 @default.
- W1981124574 hasRelatedWork W2106340219 @default.
- W1981124574 hasRelatedWork W2127431746 @default.
- W1981124574 hasRelatedWork W2379048772 @default.